Through DeepMind’s Alphafold system, scientists can discern the intricate structures of proteins, facilitating the targeted design of drug compounds to bind precisely to specific regions of ...

Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Decades ago, drug discovery was driven by trial and error in the lab. Today, the field has advanced alongside the rise of vast chemical, biological, and ...

Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...

Proteins play a crucial role in nearly all biological processes, yet predicting their complex interactions and designing ...

Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...